agilon health, inc. Increase (Decrease) in Operating Capital
agilon health, inc. (AGL) reported Increase (Decrease) in Operating Capital of $122.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingCapital · last filed 2026-08-05
- agilon health, inc. increase (decrease) in operating capital for the quarter ending 2026-06-30 was $113.99M.
- agilon health, inc. increase (decrease) in operating capital for the quarter ending 2026-03-31 was $8.43M, a 78.27% decline year-over-year.
- agilon health, inc. increase (decrease) in operating capital for the quarter ending 2025-09-30 was -$92.72M.
- agilon health, inc. increase (decrease) in operating capital for the quarter ending 2025-06-30 was -$52.88M, a 1429.52% decline year-over-year.
| Period end | Increase (Decrease) in Operating Capital 3 month | Increase (Decrease) in Operating Capital 6 month | Increase (Decrease) in Operating Capital 6 month as first filed | Increase (Decrease) in Operating Capital 9 month |
|---|---|---|---|---|
| 2026-06-30 | $113.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $122.42M 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | $8.43M 10-Q · filed 2026-05-06 | |||
| 2025-09-30 | -$92.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$145.60M derived: sum of 2 quarters · filed 2026-08-05 | -$106.80M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | -$52.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$14.08M 10-Q · filed 2026-08-05 | ||
| 2025-03-31 | $38.79M 10-Q · filed 2026-05-06 | |||
| 2024-09-30 | -$92.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$88.16M derived: sum of 2 quarters · filed 2025-11-04 | -$24.82M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $3.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $67.31M 10-Q · filed 2025-08-04 | ||
| 2024-03-31 | $63.34M 10-Q · filed 2025-05-06 | |||
| 2023-09-30 | -$6.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $14.22M derived: sum of 2 quarters · filed 2024-11-07 | $105.69M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $20.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $111.96M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $91.47M 10-Q · filed 2024-05-07 | |||
| 2022-09-30 | -$16.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $29.36M derived: sum of 2 quarters · filed 2023-11-02 | $59.62M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $46.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $76.57M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $30.25M 10-Q · filed 2023-05-09 | |||
| 2021-09-30 | -$2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $14.04M derived: sum of 2 quarters · filed 2022-11-03 | $47.62M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $16.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $50.21M 10-Q · filed 2022-08-04 | -$50.21M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $33.58M 10-Q · filed 2022-05-05 | |||
| 2020-09-30 | $41.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $3.96M derived: sum of 2 quarters · filed 2021-10-28 | $19.26M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | -$37.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$21.77M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $15.30M 10-Q · filed 2021-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |